However, despite these beneficial effects in RA patients’ treatment outcome, high therapeutic costs and adverse drug reactions – such as severe infections, congestive heart failure, and so forth [6] – limit a broad application of TNFα antagonists in RA. Here, TNF is linked to rheumatoid arthritis.